drugs

Showing 15 posts of 771 posts found.

jj

J&J exits insulin pump business, rival looks to scoop patients

October 10, 2017
Manufacturing and Production Johnson & Johnson, biotech, diabetes, drugs, pharma, pharmaceutical

Johnson & Johnson’s Animas Corporation will cease business and close operations after the pharma giant could not find a buyer …

roche_close

Roche’s 99% accurate Zika test receives FDA approval

October 9, 2017
Sales and Marketing Roche, Zika, biotech, drugs, pharma, pharmaceutical

Roche has revealed that the FDA has given approval to its cobas Zika test to determine whether a blood sample …

contraceptive-pills-849413_960_720

Trump sweeps away birth control coverage

October 9, 2017
Medical Communications, Sales and Marketing President trump, Trump, biotech, birth control, drugs, pharma, pharmaceutical

Part of Obama’s Affordable Care Act included the provision that employer-provided health insurance must cover birth control, President Trump has …

sleeping_man

Battery implant approved to treat sleep apnea

October 9, 2017
Sales and Marketing FDA, biotech, drugs, pharma, pharmaceutical

The FDA has announced the approval of a new form of treatment for central sleep apnea, in the form of …

Sanofi promotes global head of diabetes to expand role

October 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, biotech, diabetes, drugs, pharma, pharmaceutical

Sanofi has promoted Stefan Oelrich to the position of Executive Vice President of Diabetes and Cardiovascular (DCV), giving him a …

androgel

AbbVie hit with $140m fine over fraudulent marketing of Androgel

October 6, 2017
Medical Communications, Sales and Marketing AbbVie, androgel, biotech, drugs, pharma, pharmaceutical

AbbVie has been stung with a $140 million damages award to a man that suffered a heart attack after using …

bayer_cross_2

Bayer forced to halt huge study into key drug

October 6, 2017
Medical Communications, Research and Development Bayer, Janssen, Xarelto, biotech, drugs, pharma, pharmaceutical

Bayer, and development partner Janssen, have been forced to stop a Phase 3 trial looking at expanding the indication of …

aspen

South Africa’s over-charging case against Aspen dissolves, remains against big names

October 6, 2017
Medical Communications, Sales and Marketing Genentech, Pfizer, Roche, aspen, biotech, drugs, pharma, pharmaceutical

South Africa’s Competition Commission has admitted that there is no case to be heard against Aspen and Equity, in regards …

Merck KGaA promotes from within new MEA head

October 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, biotech, drugs, pharma, pharmaceutical

Merck KGaA has installed a new head of its healthcare business for the Middle East, Africa and Turkey (MEA) region, …

culture

Gonorrhoea is just the tip of the antimicrobial resistance iceberg

October 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NovaBiotics, biotech, drugs, gonorrhoea, pharma, pharmaceutical

Dr Deborah O’Neil, Chief Executive and Scientific Officer at NovaBiotics, discusses the WHO-recognised threat of ‘super gonorrhoea’ and the antimicrobial …

fpr4et-xlarge_trans_nvbqzqnjv4bqrqsyshnmi5jqhkavocpkgbkoqxwcrp1qzr8w2tfjptk

England set to adopt opt-out organ donation

October 5, 2017
Medical Communications biotech, drugs, organ donation, pharma, pharmaceutical

In a major change for the healthcare system in England, admittedly one that was easy to be lost among the …

ema_interior

57% of cancer drugs uses approved by EMA show no benefit

October 5, 2017
Sales and Marketing EMA, biotech, drugs, oncology, pharma, pharmaceutical

A new study conducted by King’s College London and LSE has found that of 48 treatments approved between 2009 and …

mylan_building_3

Mylan receives shock approval of Teva blockbuster

October 5, 2017
Sales and Marketing Copaxone, Mylan, Teva, biotech, drugs, pharma, pharmaceutical

Mylan had been knocked back by the FDA in its quest to have its generic version of Copaxone approved earlier …

amgen_hq

CytomX scores deal with Amgen worth potential $1.5bn

October 4, 2017
Research and Development, Sales and Marketing Amgen, biotech, cytomx, drugs, pharma, pharmaceutical

CytomX Therapeutics and Amgen have signed a deal that could be worth a potential $1.5 billion. The agreement will see …

The Gateway to Local Adoption Series

Latest content